BlackRock Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.57M | Sell |
98,236
-427
| -0.4% | -$6.81K | ﹤0.01% | 1579 |
|
|
2016
Q3 | $1.64M | Buy |
98,663
+1,907
| +2% | +$31.7K | ﹤0.01% | 1511 |
|
|
2016
Q2 | $1.08M | Buy |
96,756
+77,051
| +391% | +$862K | ﹤0.01% | 1695 |
|
|
2016
Q1 | $165K | Buy |
19,705
+1,459
| +8% | +$12.2K | ﹤0.01% | 2617 |
|
|
2015
Q4 | $170K | Sell |
18,246
-8,204
| -31% | -$76.4K | ﹤0.01% | 2616 |
|
|
2015
Q3 | $298K | Sell |
26,450
-605
| -2% | -$6.82K | ﹤0.01% | 2469 |
|
|
2015
Q2 | $343K | Buy |
27,055
+5,150
| +24% | +$65.3K | ﹤0.01% | 2415 |
|
|
2015
Q1 | $204K | Buy |
21,905
+329
| +2% | +$3.06K | ﹤0.01% | 2633 |
|
|
2014
Q4 | $309K | Buy |
21,576
+1,403
| +7% | +$20.1K | ﹤0.01% | 2318 |
|
|
2014
Q3 | $209K | Sell |
20,173
-681
| -3% | -$7.06K | ﹤0.01% | 2548 |
|
|
2014
Q2 | $337K | Sell |
20,854
-11,932
| -36% | -$193K | ﹤0.01% | 2271 |
|
|
2014
Q1 | $533K | Sell |
32,786
-28,329
| -46% | -$461K | ﹤0.01% | 1972 |
|
|
2013
Q4 | $758K | Buy |
61,115
+40,482
| +196% | +$502K | ﹤0.01% | 1684 |
|
|
2013
Q3 | $226K | Sell |
20,633
-43,203
| -68% | -$473K | ﹤0.01% | 2461 |
|
|
2013
Q2 | $516K | Buy |
+63,836
| New | +$516K | ﹤0.01% | 1796 |
|